Belgium· BE-AMP-SAM097097-00

Minims Cyclopentolate Chlorhydrate 5 mg/ml

A cyclopentolate product containing cyclopentolate hydrochloride, registered in Belgium by Bausch + Lomb Ireland. The same ATC class is registered in 16 of our 19 countries.

ATC S01FA04

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cyclopentolate hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cyclopentolate is registered in 16 of 19 countries.

Countries holding a registration under ATC S01FA04 (cyclopentolate), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search cyclopentolate products by name

Cyclopentolate · ATC S01FA04

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Cyclopentolate Hydrochloride
Manufacturer: Bausch + Lomb Ireland
Country: Belgium (BE)
ATC code: S01FA04
ATC class: Cyclopentolate
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 1

be_apb
0025635

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for cyclopentolate.

Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cyclopentolate against other medicines How interaction checks work

Cyclopentolate · interactions on record

3 records

3 moderate

Most severe, free to view

PhenylephrineC01CA06moderate
PhysostigmineS01EB05moderate
PhysostigmineV03AB19moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyclopentolate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyclopentolate products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Bulgaria · Цикловижън
Cyprus · Cyclogyl
Czechia · Cyclopentolate Olikla
Germany · Cyclopentolat Alcon, Zyklolat Edo
Denmark · Cyclogyl
Spain · Colirofta Ciclopléjico
Finland · Oftan Syklo
France · Skiacol
Greece · Cyclogyl
Hungary · Humapent
Ireland · Minims
Iceland · Cyclogyl
Italy · Ciclolux, Plegik
Lithuania · Cyclogyl
Luxembourg · Minims, Minims Cyclopentolate Chlorhydrate Bausch + Lomb Ireland Limited
Malta · Minims Cyclopentolate Hydrochloride Bausch + Lomb Ireland
Netherlands · Cyclogyl, Minims Cyclopentolaathydrochloride Bausch + Lomb Ireland Limited
Norway · Cyclopentolat Bausch + Lomb Ireland Limited
Poland · Cykloftyal
Portugal · Cicloplegicedol, Midriodavi
Sweden · Cyclogyl, Cyclopentolat Bausch & Lomb
Slovakia · Cyclopentolate Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d3619e51-5c1a-4d80-ac17-2cba0de6870c
GET /v1/drugs/d3619e51-5c1a-4d80-ac17-2cba0de6870c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Minims Cyclopentolate Chlorhydrate 5 mg/ml",
  "name_fr": "Minims Cyclopentolate Chlorhydrate 5 mg/ml",
  "name_nl": "Minims Cyclopentolate Chlorhydrate 5 mg/ml",
  "amp_code": "SAM097097-00",
  "strengths": [
    "5.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Cyclopentolate Hydrochloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Cyclopentolate",
  "authorisation_numbers": [
    "BE097097"
  ]
}

API reference MCP server Plans

See everything about cyclopentolate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console